Northern Trust Corp Vera Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 365,519 shares of VERA stock, worth $15.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

365,519

Previous 372,454 1.86%

Holding current value

$15.9 Million

Previous $16.1 Million 17.66%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$33.72 - $48.82 $233,848 - $338,566	-6,935 Reduced 1.86%	365,519 $13.2 Million
Q1 2024 May 14, 2024	BUY	$14.91 - $49.14 $754,729 - $2.49 Million	50,619 Added 15.73%	372,454 $16.1 Million
Q4 2023 Feb 13, 2024	BUY	$9.29 - $16.0 $244,614 - $421,296	26,331 Added 8.91%	321,835 $4.95 Million
Q3 2023 Nov 13, 2023	BUY	$13.71 - $19.64 $247,342 - $354,325	18,041 Added 6.5%	295,504 $4.05 Million
Q2 2023 Aug 11, 2023	BUY	$6.11 - $17.83 $513,716 - $1.5 Million	84,078 Added 43.48%	277,463 $4.45 Million
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $367,360 - $1.24 Million	67,904 Added 54.11%	193,385 $1.5 Million
Q4 2022 Feb 13, 2023	BUY	$15.74 - $22.19 $167,017 - $235,458	10,611 Added 9.24%	125,481 $2.43 Million
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $31,848 - $53,544	2,400 Added 2.13%	114,870 $2.45 Million
Q2 2022 Aug 12, 2022	BUY	$12.82 - $23.4 $39,267 - $71,674	3,063 Added 2.8%	112,470 $1.53 Million
Q1 2022 May 13, 2022	BUY	$17.8 - $28.06 $561,661 - $885,405	31,554 Added 40.53%	109,407 $2.57 Million
Q4 2021 Feb 08, 2022	BUY	$15.01 - $35.8 $278,255 - $663,660	18,538 Added 31.25%	77,853 $2.08 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $30.6 $813,208 - $1.82 Million	59,315 New	59,315 $1.03 Million

Others Institutions Holding VERA

# of Institutions

182

Shares Held

54.7M

Call Options Held

42.2K

Put Options Held

121K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.17B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Vera Therapeutics, Inc. Transaction History